NCT00505336View on ClinicalTrials.gov

The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

December 31, 2008

Conditions
Diastolic Heart Failure
Interventions
DRUG

Eplerenone

oral Eplerenone titrated to 50mg for duration of 12 months

OTHER

No additional treatment

normal disease modifying therapy for heart failure i.e. ACE-I, beta blockers

DRUG

Atorvastatin

oral Atorvastatin 40mg

Trial Locations (1)

4

St Vincent's University Hospital, Ballsbridge

All Listed Sponsors
lead

St Vincent's University Hospital, Ireland

OTHER

NCT00505336 - The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure | Biotech Hunter | Biotech Hunter